ORCID Research Profile
MIQUEL BERNARDO ARROYO
Position: Director of Barcelona
Clinic Schizophrenia Unit;
Full Professor of Psychiatry
Research team
Rosa Catalan Campos
Assistant Professor
rosacatalan (at) ub.edu
Eduardo Parellada Rodon
Assistant Professor
eduardparelladarodon (at) ub.edu
Rafael Penades Rubio
Assistant Professor
rafaelpenades (at) ub.edu
Mercè Torra Santamaria
Assistant Professor
mtorra (at) ub.edu
Silvia Amoretti Guadall
Collaborator
amoretti (at) clinic.cat
Miquel Bioque Alcazar
Collaborator
Clemente Garcia Rizo
Collaborator
Bibiana Cabrera Llorca
Collaborator
Gisela Mezquida Mateos
Collaborator
Alexander Gonzalez Rodriguez
Collaborator
Contact details
Prof. Miquel Bernardo Arroyo
Department of Psychiatry and Clinical Psychobiology
Faculty of Medicine, Casanovas 143
08036 Barcelona (Spain)
+ 34 93 227 54 00 # 3142
bernardo (at) clinic.ub.es
Research Interests
The Clinical Schizophrenia Group (GEC) has been recognized as a consolidated research group since 2005 (2014SGR 441) by the Agència de Gestió d’Ajuts Universitaris i de Recerca, AGAUR. This interdisciplinary group focuses on schizophrenia and related disorders in clinical care, research and teaching. The research is centered on the study of first episodes, childhood and adolescent-onset, resistant and comorbid schizophrenia. The main lines include neuroimaging, genetics, neurobiology and molecular psychiatry; neuropsychology, psychoeducation and psychometric evaluation; psychopharmacology; physical health; high-risk population, A program has been developed for characterizing and preventing second psychotic episodes. We have active collaboration (multicenter studies in translational and innovative investigation) with other IDIBAPS, CIBERSAM, and international research groups. We collaborate with a European network of research in schizophrenia and maintain close relationship to American research networks.
Current Research Lines
- Physical health
- Neuroimaging, genetics and neurobiology, molecular psychiatry
- Neuropsychology, psychoeducation and psychometric evaluation
- Psychopharmacology
- High-risk population, early-onset and first and second episodes of psychosis
Technologies / methods
- Functional and structural neuroimaging techniques.
- Genetic and molecular biological techniques. Patent acquired by AB-Biotics and developed by UB, IDIBAPS, Hospital Clínic and CIBERSAM. Method for predicting the onset extrapiramidal symptoms (EPS) induced by an antipsychotic-based treatment.
- Psychometric evaluation.
Highlighted publications
· Kirkpatrick B, Miller B, Garcia-Rizo C, Fernandez-Egea E, Bernardo M. (2012) Is Abnormal Glucose tolerance In Antipsychotic-Naïve with Nonaffective Psychosis Confounded by Poor Health Habits? Schizophr Bull 38(2): 280-284.
· Penades R, Pujol N, Catalán R, Masana G, Rametti G, García-Rizo C, Bargalló N, Gastó C, Bernardo M, Junqué C. (2013) Brain effects of cognitive remediation therapy in schizophrenia: a structural and functional neuroimaging study. Biol Psychiatry. 15;73(10):1015-23.
· Garcia-Rizo C,Kirkpatrick B, Fernandez-Egea E, Oliveira C, Meseguer A, Grande I, Undurraga J, Vieta E, Bernardo M. (2104). Is bipolar disorder an endocrine condition?: Glucose abnormalities in bipolar disorder. Acta Psychiatrica Scandinavica;129(1):73-74.
· Bioque M, Llerena A, Cabrera B, Mezquida G, Lobo A, Gonzáles-Pinto A, Díaz-Caneja CM, Corripio I, Aguilar EJ, Bulbena A, Castro-Fornieles J, Vieta E, Lafuente A, Mas S, Parellada M, Saiz-Ruiz J, Cuesta MJ, Bernardo M; andPEPs GROUP. A pharmacovigilancestudy in firstepisode of psychosis; Psychopharmacologicalinterventionsand safety profiles in theproject. Int J Neuropsychopharmacol. 2015 Oct 27.
· Batalla A, Bargalló N, Gassó P, Molina O, Pareto D, Mas S, Roca JM, Bernardo M, Lafuente A, Parellada E. (2015). Apoptoticmarkers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls. Transl Psychiatry. Aug 25;5:e626.